CA
ABMD

Commerzbank Aktiengesellschaft’s Abiomed Inc ABMD Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,900
Closed -$116K – 1002
2018
Q4 		$116K Sell
15,900
-14,100
-47% -$4.9M ﹤0.01% 886
2018
Q3 		$2.61M Buy
+30,000
New +$11.8M 0.02% 388

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Commerzbank Aktiengesellschaft's ABMD Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 4,286 shares — an estimated $622K sold.

Commerzbank Aktiengesellschaft first reported a position in ABMD in Q2 2018 and held it in 8 quarters. The position peaked at $2.6M in Q4 2019. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 4,286 Abiomed Inc shares in Q2 2020, an estimated $622K.
  • Commerzbank Aktiengesellschaft first reported a position in Abiomed Inc in Q2 2018 and held it in 8 quarters.
  • Commerzbank Aktiengesellschaft's Abiomed Inc position peaked at $2.6M in Q4 2019.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.